Raymond James Reiterates Outperform on Fulgent Genetics, Raises Price Target to $25
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
Raymond James analyst Andrew Cooper reiterates Fulgent Genetics (NASDAQ:FLGT) with a Outperform and raises the price target from $24 to $25.
Raymond James analyst Andrew Cooper reiterates Fulgent Genetics (NASDAQ:FLGT) with a Outperform and raises the price target from $24 to $25.